NanoVibronix, Inc.
NAOV
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease paā¦ read more
Healthcare
Medical Devices
10 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$4.02
Price-6.73%
-$0.29
1Y
Price
Market Cap
$3.204m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years+118.4%
EBITDA Margin+70.6%
Net Profit Margin-276.7%
Free Cash Flow MarginRevenue
$2.685m
+5.0%
1y CAGR+73.5%
3y CAGR+41.2%
5y CAGREarnings
-$3.572m
+3.6%
1y CAGR+11.9%
3y CAGR+24.4%
5y CAGREPS
-$8.17
+40.5%
1y CAGR+40.2%
3y CAGR+46.7%
5y CAGRBook Value
$42.464m
$54.383m
Assets$11.919m
Liabilities$3.170m
DebtDebt to Assets
5.8%
-0.5x
Debt to EBITDAFree Cash Flow
-$7.281m
-189.0%
1y CAGR-36.7%
3y CAGR-42.8%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company